An experimental pain-relieving drug delivery method for farm animals using microneedle patches may not have delivered an ...
Adagene (ADAG) stock and Palvella Therapeutics (PVLA) stock rise as the FDA issued Fast Track Designations for the companies' ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...
Clinical Trials Arena on MSN
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
The FDA has delayed tolebrutinib’s review date again, as Sanofi also posted a Phase III failure for the MS candidate.
Life & Style on MSN
Why Experts Say This New Weight Loss Drug Could Be a Game Changer
Retatrutide, a new experimental weight-loss drug, targets three hormones and shows promising results far beyond current ...
South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...
Investor's Business Daily on MSN
Monte Rosa scores a win in prostate cancer, and rockets to a four-year high
Monte Rosa Therapeutics surged Tuesday after the biotech said every patients in a prostate cancer study responded to its ...
Smithsonian Magazine on MSN
Scientists Engineered Cancer-Fighting Cells Inside Patients’ Bodies—and Two Early Trials Show Promise
Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback